DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
Founder’s Corner Investing to create transformative therapeutics for patients. The Tree of Life Darwin’s Tree of Life (1837) Darwin’s Origin of Species is the foundation of evolutionary biology, and is unquestionably one of the most important and influential texts in all of science. His thoughts on natural selection and how new species can branch out […]
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Smsr B1, L.P. | 2023 | Active deployment | n/a | $121M | 0 |
| 565 Spv I, L.P. | 2020 | Mature | n/a | $11,295 | 0 |
| SMM Spv I, LLC | 2016 | Harvest | $7.0M | $1.6B | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Investor Portal | n/a | n/a | n/a | n/a | Unknown | Sep 12, 2026 |
| Coultreon Biopharma | n/a | Series a | $125M | n/a | Unknown | Apr 28, 2026 |
| Bonum Therapeutics, Inc. | Wa | n/a | n/a | Mitchell Mutz | Strongly supported | Apr 17, 2026 |
| Ambrosia Biosciences Inc. | Co | Series b | $100M | n/a | Unknown | Mar 31, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. | Samsara Biocapital, LLC | 2 | 2 | Sep 12, 2026 | Recurring |
| LAS Olas Venture Capital | Samsara Biocapital, LLC | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | Unless Management LP | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | Rice Park Capital | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | 4x4 Capital | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | Plural Uk Management | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | FGC Management Co., LLC | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | DN Capital (US), Inc | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | Mcwhorter Ventures, LLC | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | 5th Century Partners | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | Carnelian Energy Capital Management, LP | 1 | 1 | Sep 12, 2026 | One time |
| Samsara Biocapital, LLC | Galapagos | 1 | 1 | Apr 28, 2026 | One time |
| Samsara Biocapital, LLC | Balyasny Asset Management L.P. | 1 | 1 | Apr 28, 2026 | One time |
| Samsara Biocapital, LLC | Regeneron Ventures | 1 | 1 | Apr 28, 2026 | One time |
| Blueprint Local LLC | Samsara Biocapital, LLC | 1 | 1 | Sep 12, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Riki Harada (Vice President of Finance), Indrani Rebbapragada (Sr. Dir Project & Portfolio Management), Noushin Vaccani (Exec Assistant/Operations Manager), Meysis Lam (Accounting Supervisor – Portfolio), Marie Chang (Associate Director, Finance), Srini’s Take (Founder’s Corner), Mike Dybbs (Partner), Abe Bassan (Partner), Mitchell Mutz (Senior Principal), Matt Eckler (Principal, Public Investing), Clara Dong (Senior Associate), Jim P. Edwards (Venture Partner).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan